7/3/2013

The FDA has granted Glenmark Pharmaceuticals approval for its Rizatriptan Benzoate orally disintegrating tablets in the 5- and 10-milligram strengths to address migraine. The drug is a generic version of Merck's Maxalt MLT tablets.

Related Summaries